Assessments of the Utilities of CSF NPTX2 for Disease Progression in Cognitively Normal Individuals Who Progress to Clinical MCI and AD. Shaw LM, Galasko D. Ann Neurol 2023;94:618-619.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shaw LM, Galasko D. Assessments of the Utilities of CSF NPTX2 for Disease Progression in Cognitively Normal Individuals Who Progress to Clinical MCI and AD. Ann Neurol 2023;94:618-619.
PMID: 37614206